Asymchem Laboratories (Tianjin) Co., Ltd. (HKG:6821)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
112.40
+7.40 (7.05%)
Apr 28, 2026, 4:08 PM HKT
121.92%
Market Cap 47.80B
Revenue (ttm) 7.88B
Net Income (ttm) 1.26B
Shares Out n/a
EPS (ttm) 3.53
PE Ratio 37.88
Forward PE 27.85
Dividend 1.20 (1.29%)
Ex-Dividend Date Jun 25, 2025
Volume 2,575,200
Average Volume 944,868
Open 100.00
Previous Close 105.00
Day's Range 100.00 - 116.10
52-Week Range 49.05 - 116.60
Beta 0.07
RSI 72.03
Earnings Date Mar 30, 2026

About HKG:6821

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business. The company also engages in ke... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 10,617
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6821
Full Company Profile

Financial Performance

In 2025, HKG:6821's revenue was 6.67 billion, an increase of 14.91% compared to the previous year's 5.80 billion. Earnings were 1.13 billion, an increase of 19.35%.

Financial numbers in CNY

News

There is no news available yet.